Similar Natural Products in NPASS
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC68114 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
range |
Tanimoto Coefficient |
0-0.1 | 4880 |
0.1-0.2 | 20473 |
0.2-0.3 | 4731 |
0.3-0.4 | 600 |
0.4-0.5 | 171 |
0.5-0.6 | 28 |
0.6-0.7 | 5 |
0.7-0.8 | 1 |
0.8-0.85 | 0 |
0.85-0.9 | 0 |
0.9-0.95 | 0 |
0.95-1 | 0 |
  Similar Clinical/Approved Drugs
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC68114 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
range |
Tanimoto Coefficient |
0-0.1 | 4342 |
0.1-0.2 | 3900 |
0.2-0.3 | 633 |
0.3-0.4 | 198 |
0.4-0.5 | 60 |
0.5-0.6 | 18 |
0.6-0.7 | 7 |
0.7-0.8 | 2 |
0.8-0.85 | 0 |
0.85-0.9 | 1 |
0.9-0.95 | 0 |
0.95-1 | 0 |
Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8519 |
High Similarity |
NPD9038 |
Approved |
0.7407 |
Intermediate Similarity |
NPD8559 |
Clinical (unspecified phase) |
0.7188 |
Intermediate Similarity |
NPD9679 |
Clinical (unspecified phase) |
0.6897 |
Remote Similarity |
NPD8219 |
Approved |
0.6897 |
Remote Similarity |
NPD8220 |
Approved |
0.6774 |
Remote Similarity |
NPD8218 |
Approved |
0.6364 |
Remote Similarity |
NPD8237 |
Approved |
0.6061 |
Remote Similarity |
NPD8234 |
Approved |
0.6061 |
Remote Similarity |
NPD8235 |
Approved |
0.6061 |
Remote Similarity |
NPD8236 |
Phase 1 |
0.5862 |
Remote Similarity |
NPD7385 |
Approved |
0.5833 |
Remote Similarity |
NPD9208 |
Clinical (unspecified phase) |
0.5833 |
Remote Similarity |
NPD8612 |
Approved |
0.5641
|
Remote Similarity |
NPD5799 |
Discontinued |